These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21635969)

  • 1. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.
    Deshpande A; Pasupuleti V; Patel P; Ajani G; Hall G; Hu B; Jain A; Rolston DD
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):665-669.e1. PubMed ID: 21635969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.
    Nemat H; Khan R; Ashraf MS; Matta M; Ahmed S; Edwards BT; Hussain R; Lesser M; Pekmezaris R; Dlugacz Y; Wolf-Klein G
    Am J Gastroenterol; 2009 Aug; 104(8):2035-41. PubMed ID: 19367273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield.
    Deshpande A; Pasupuleti V; Patel P; Pant C; Pagadala M; Hall G; Hu B; Jain A; Rolston DD; Sferra TJ; Atreja A
    Curr Med Res Opin; 2012 Sep; 28(9):1553-60. PubMed ID: 22852871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease.
    Debast SB; van Kregten E; Oskam KM; van den Berg T; Van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2008 Jun; 14(6):622-4. PubMed ID: 18393996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.
    Mattner F; Winterfeld I; Mattner L
    Scand J Infect Dis; 2012 Aug; 44(8):578-85. PubMed ID: 22404319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
    O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
    J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool.
    Song L; Zhao M; Duffy DC; Hansen J; Shields K; Wungjiranirun M; Chen X; Xu H; Leffler DA; Sambol SP; Gerding DN; Kelly CP; Pollock NR
    J Clin Microbiol; 2015 Oct; 53(10):3204-12. PubMed ID: 26202120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
    Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
    Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.